Allison Taylor, PA
Physician Assistant · Bismarck, NDNPI 1902518657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$381
- Medtronic$363
- Novo Nordisk$268
- Sanofi-aventis U.S. LLC$149
- AstraZeneca$142
- Boehringer Ingelheim$126
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,755100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $381 |
| Medtronic | 6 | $363 |
| Novo Nordisk | 15 | $268 |
| Sanofi-aventis U.S. LLC | 2 | $149 |
| AstraZeneca(2 entities) | 8 | $142 |
| Boehringer Ingelheim | 6 | $126 |
| Novartis | 7 | $105 |
| Lilly USA, LLC | 5 | $85 |
| AbbVie | 3 | $77 |
| Travere Therapeutics, Inc. | 4 | $77 |
| UCB, Inc. | 4 | $73 |
| Biogen | 4 | $69 |
| Mallinckrodt Hospital Products Inc. | 3 | $61 |
| Pfizer | 4 | $59 |
| EMD Serono, Inc. | 2 | $48 |
| Johnson & Johnson | 3 | $48 |
| Lundbeck LLC | 3 | $47 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| Tandem Diabetes Care, Inc. | 3 | $42 |
| Dexcom, Inc. | 2 | $42 |
| Grifols USA, LLC | 2 | $41 |
| Radius Health, Inc. | 2 | $41 |
| Boston Scientific | 1 | $39 |
| Eisai Inc. | 2 | $34 |
| Octapharma USA, Inc. | 1 | $32 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $29 |
| Piramal Critical Care | 1 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
| United Therapeutics Corporation | 1 | $16 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amylyx Pharmaceuticals, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$151
- EVENITY$109
- MINIMED 780G$105
How this compares
$2,755 in reported general payments places this provider in the 90th percentile of 355 physician assistant providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 148 | $173,046 |
| OzempicSemaglutide | 87 | $119,882 |
| JardianceEmpagliflozin | 199 | $117,938 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 68 | $62,382 |
| Tresiba Flextouch U-100Insulin Degludec | 115 | $61,577 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 24 | $46,133 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $43,259 |
| TrulicityDulaglutide | 26 | $30,981 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $26,341 |
| LyumjevInsulin Lispro-Aabc | 12 | $24,267 |
| FarxigaDapagliflozin Propanediol | 32 | $23,701 |
| Novolog FlexpenInsulin Aspart | 97 | $23,072 |
| Humalog Kwikpen U-200Insulin Lispro | 19 | $22,022 |
| FiaspInsulin Aspart (Niacinamide) | 17 | $19,970 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 37 | $18,889 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Insulin Lispro | $85 | $230,043207 claims |
| Novo NordiskOzempic, Fiasp, Novolog | $268 | $144,704119 claims |
| Boehringer IngelheimJardiance, Synjardy | $126 | $128,500215 claims |
| AstraZenecaFarxiga | $142 | $23,70132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 355 physician assistant providers in North Dakota.
Other physician assistant in Bismarck
- Hannah SmallBismarck$10K
- Micheal HenkeBismarck$6K
- Sommer WamsleyBismarck$5K
- Burton MollmanBismarck$5K
- Brooke ArndorferBismarck$5K
- Tara Curtis HaberlockBismarck$4K
- Steele TescherBismarck$4K
- Kari ThomasBismarck$3K
- Kelsie TescherBismarck$3K
- Kari DatzBismarck$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.